Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
B-R 31 ICE CREAM, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 16%, Exceeds Full-Year Plan
2268 B-R 31 ICE CREAM CO.,LTD. 【J-GAAP】
Earnings ReportB-R 31 ICE CREAM CO.,LTD. <2268> [TSE Std] announced its financial results after the market closed on October 23rd (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending December 2025 (January to September) increased 15.7% from the same period last year, reaching 3.09 billion yen. Progress toward the full-year plan of 2.46 billion yen is 125.9%, already exceeding the target and also exceeding the five-year average of 101.4%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary loss for the October to December period (4Q) is expected to expand to a loss of 0.63 billion yen (compared to a loss of 0.28 billion yen in the same period last year). However, if the fourth-quarter performance remains at the same level as the first three quarters, the full-year plan may be increased.
In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit grew 23.4% from the same period last year, reaching 1.40 billion yen. The operating profit margin rose from 13.1% in the same period last year to 13.5%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Sep, 2023 | 18,810 | 1,937 | 1,976 | 1,281 | 133.0 | 106.2 | Oct 20, 2023 | J-GAAP |
| Jan - Sep, 2024 | 23,138 | 2,692 | 2,676 | 1,705 | 177.0 | 112.1 | Oct 18, 2024 | J-GAAP |
| Jan - Sep, 2025 | 25,853 | 3,052 | 3,096 | 1,988 | 206.3 | 125.9 | Oct 23, 2025 | J-GAAP |
| YoY | +11.7% | +13.4% | +15.7% | +16.6% | +16.6% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 16,490 | 842 | 849 | 561 | 58.3 | 30 | Feb 10, 2025 | J-GAAP |
| Jul - Dec, 2025 Guidance | 17,043 | 735 | 768 | 459 | 47.6 | 25 | Jul 24, 2025 | J-GAAP |
| YoY | +3.4% | -12.7% | -9.5% | -18.2% | -18.2% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 24,760 | 1,828 | 1,860 | 1,201 | 124.7 | 40 | Feb 9, 2024 | J-GAAP |
| Dec, 2024 | 30,688 | 2,363 | 2,387 | 1,543 | 160.2 | 50 | Feb 10, 2025 | J-GAAP |
| Dec, 2025 Guidance | 32,860 | 2,430 | 2,460 | 1,550 | 160.9 | 50 | Feb 10, 2025 | J-GAAP |
| YoY | +7.1% | +2.8% | +3.1% | +0.5% | +0.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 8,940 | 1,171 | 1,138 | 723 | 75.1 | 13.1 | Oct 18, 2024 | J-GAAP |
| Oct - Dec, 2024 | 7,550 | -329 | -289 | -162 | -16.8 | -4.4 | Feb 10, 2025 | J-GAAP |
| Jan - Mar, 2025 | 6,585 | 420 | 378 | 242 | 25.2 | 6.4 | Apr 22, 2025 | J-GAAP |
| Apr - Jun, 2025 | 9,232 | 1,275 | 1,314 | 849 | 88.1 | 13.8 | Jul 24, 2025 | J-GAAP |
| Jul - Sep, 2025 | 10,036 | 1,357 | 1,404 | 897 | 93.1 | 13.5 | Oct 23, 2025 | J-GAAP |
| YoY | +12.3% | +15.9% | +23.4% | +24.1% | +24.0% |
Related Articles
SE Holdings&Incubations, First Half Ordinary Profit Decreases by 37%, Jul-Sep Ordinary Profit Decreases by 47%
TAKARA BIO, Net Income Forecast for First Half Loss Widened in Downward Revision
AI Inc, Net Income Forecast for First Half Turns to Profit, Exceeds Expectations
Nihon M&A Center, Ordinary Profit Forecast for First Half Revised Upward by 22%
Medical Ikkou, Ordinary Profit Forecast for the Fiscal Year Revised Downward to an Unexpected 1% Decrease
MIRAI INDUSTRY, First Half Ordinary Profit Decreases by 8%
DAIMARU ENAWIN, Jul-Sep (2Q) Ordinary Profit Decreases by 23%
Kosei Securities, First Half Ordinary Profit Turns to Profit, Jul-Sep Ordinary Profit Turns to Profit
DAIREI, Ordinary Profit Forecast for First Half Revised Downward to an Unexpected 31% Decrease
ISHIZUKA GLASS, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 4%